Home › NDC Lookup › Ingredients › Angelica Archangelica, Kali Muriaticum,... › 58048-0005-01
Lyme and Co-Infection Nosode Angelica Archangelica, Kali Muriaticum, Yucca Filamentosa, Cartilago Suis, Phytolacca Decandra, Hydrastis Canadensis, Rhus Tox, Causticum, Magnesia Phosphorica, Manganum Metallicum, Oxalicum Acidum, Arnica Montana, Babesia Microti, Borrelia Burgdorferi No 2 [hp_X]/mL; 3 [hp_X]/mL; 3 [hp_X]/mL; 4 [hp_X]/mL; 4 [hp_X]/mL; 5 [hp_X]/mL; 6 [hp_X]/mL; 6 [ Liquid, 60 mL — NDC 58048-0005-01 package photo
Label image from the product's FDA listing (DailyMed) — may show a different pack size or an older label revision.

Lyme and Co-Infection Nosode Angelica Archangelica, Kali Muriaticum, Yucca Filamentosa, Cartilago Suis, Phytolacca Decandra, Hydrastis Canadensis, Rhus Tox, Causticum, Magnesia Phosphorica, Manganum Metallicum, Oxalicum Acidum, Arnica Montana, Babesia Microti, Borrelia Burgdorferi No 2 [hp_X]/mL; 3 [hp_X]/mL; 3 [hp_X]/mL; 4 [hp_X]/mL; 4 [hp_X]/mL; 5 [hp_X]/mL; 6 [hp_X]/mL; 6 [ Liquid, 60 mL — NDC 58048-0005-1 (Billing 58048-0005-01)

by Bhp Holdings, Inc. · 60 mL in 1 BOTTLE, DROPPER

This is a package of 60 mL of Lyme and Co-Infection Nosode Angelica Archangelica, Kali Muriaticum, Yucca Filamentosa, Cartilago Suis, Phytolacca Decandra, Hydrastis Canadensis, Rhus Tox, Causticum, Magnesia Phosphorica, Manganum Metallicum, Oxalicum Acidum, Arnica Montana, Babesia Microti, Borrelia Burgdorferi No 2 [hp_X]/mL; 3 [hp_X]/mL; 3 [hp_X]/mL; 4 [hp_X]/mL; 4 [hp_X]/mL; 5 [hp_X]/mL; 6 [hp_X]/mL; 6 [ Liquid from Bhp Holdings, Inc., marketed since Mar 2020 and currently FDA-listed, this package's marketing is listed to end Sep 2027. It is this product's only package size.

NDC 58048-0005-01
🏷️ FDA NDC (as labeled) 58048-0005-1 billing pads the package segment with a zero
OTC On market Non-controlled ⇄ Compare with another NDC
🗂️ FDA directory synced Oct 8, 2026 · this listing last changed Oct 8, 2026 · sources: openFDA · FDA label (DailyMed) · FDA Orange & Purple Book · First Databank · CMS NADAC, ASP, Medicare & Medicaid · RxNorm
📋 All sources & update times →

This page is curated, coded, and maintained by

Compiled from public FDA, CMS, DailyMed, NADAC, and related drug data sources. Editorial policy

NDC database record

One package, one record: these facts belong to NDC 58048-0005-1 alone.

Record
FDA NDC Directory package listing · Human OTC drug
Code segments
58048 labeler · 0005 product · 1 package
Package marketed since
Mar 17, 2020
Package marketing ended
Sep 19, 2027
Sample package
No — commercial package
Barcode (UPC-A, from the NDC)
3 5804800051 4
FDA record last changed
Oct 8, 2026

Identity & classification

Regulatory identifiers FDA, NLM and CMS codes for this package

FDA NDC (as labeled) 58048-0005-1
Product NDC 58048-0005
11-digit billing NDC 58048000501
UNII DTN01M69SN, 660YQ98I10, T6VR38UJ9I, 73ECW5WG2F, 11E6VI8VEG, ZW3Z11D0JV +12 more
SPL Set ID f6186157-256f-4454-b122-f7665e3286f4
Established class (EPC) Calculi Dissolution Agent; Anti-coagulant
Mechanism of action Acidifying Activity; Calcium Chelating Activity
Physiologic effect Decreased Coagulation Factor Activity
DEA schedule Non-controlled
Marketing category UNAPPROVED HOMEOPATHIC
Marketing status On market
FDA listing status Listed (active directory)
Marketing start 2020-03-17
Marketing end 2027-09-19
Route ORAL
Dosage form LIQUID
Substance ANGELICA ARCHANGELICA ROOT; POTASSIUM CHLORIDE; YUCCA FILAMENTOSA; SUS SCROFA CARTILAGE; PHYTOLACCA AMERICANA ROOT; GOLDENSEAL; TOXICODENDRON PUBESCENS LEAF; CAUSTICUM; MAGNESIUM PHOSPHATE, DIBASIC TRIHYDRATE; MANGANESE; OXALIC ACID; ARNICA MONTANA; BABES
Why two NDCs? The FDA registers this code as 58048-0005-1 — a 5-4-1 layout, and that's what's printed on the package and shown on DailyMed. For insurance claims, every NDC is standardized to a uniform 11-digit 5-4-2 format by adding a zero to the package segment → 58048-0005-01. Same drug, same package — only the format differs.
Where does this data come from?
Identifiers from the FDA openFDA NDC Directory and Structured Product Labeling; RxCUI from RxNorm (NLM); GPI from Medi-Span; GCN / HIC / AHFS / legend from First Databank.

Clinical

🧪 What is this product?

This is an unapproved homeopathic liquid product taken by mouth that contains plant extracts, minerals, and microbial substances. The ingredients listed are used in homeopathic practice based on traditional beliefs rather than scientific evidence. Homeopathic products are not evaluated by the FDA for safety or effectiveness. This product appears to be marketed for conditions related to Lyme disease, though homeopathic remedies have not been proven to treat or cure any disease.

Supplement & herbal interactions

🌿 Drug–supplement interaction checker →
Where does this data come from?
Plain-language summary from MedlinePlus (U.S. National Library of Medicine); supplement & herbal interactions and nutrient depletion data from the Natural Medicines database; our full guide is HelloPharmacist editorial content.

Pricing

A drug doesn't have one price. Each row is a different public payment system, and none is what you'd pay at the counter — that depends on your insurance. The ⓘ on each row explains what it measures.

Price systemPer mLPer package
Retail pharmacies payNADAC · weekly Not in the retail survey — common for institutional, discontinued, or low-volume packs.
Medicaid paysCMS SDUD · 12 mo No recent Medicaid claims on file for this NDC — rare and low-volume NDCs are suppressed in the public data.
Medicare drug plans payPart D · quarterly No Part D plan price is available for this NDC in our data.
ℹ️
No price is published for this exact package yet. CMS surveys NADAC per package size, so a different pack of the same drug often has one.
Where does this data come from?
NADAC (National Average Drug Acquisition Cost) is the CMS weekly pharmacy-acquisition-cost survey — what pharmacies pay. ASP (Average Sales Price) is the CMS Medicare Part B drug-payment file, published quarterly. Medicaid pays is computed by us from CMS State Drug Utilization Data (total reimbursed ÷ units, trailing 12 months) — gross of rebates and inclusive of dispensing fees, so it reflects what Medicaid paid, not an acquisition cost. Medicare drug plans pay is the median negotiated point-of-sale unit cost across plans listing this NDC in the CMS quarterly Prescription Drug Plan pricing files, before rebates. The VA pays is the federal contract price (FSS, and the statutory Big 4 ceiling where listed) from the VA National Acquisition Center pharmaceutical price file. All are free public government data; each measures a different payer, so the figures are not directly comparable.

Packaging — all sizes for this product

Package NDCDescription Marketing startMarketing endStatus
58048-0005-01 You're viewing this Main listing 60 mL in 1 BOTTLE, DROPPER 2020-03-17 Sep 19, 2027 Active

Therapeutic equivalents

ProductLabelerPackNADAC/unitTEStatusPrice vs. this
Lyme and Co-Infection Nosode 2 [hp_X]/mL; 3 [hp_X]/mL; 3 [hp_X]/mL; 4 [hp_X]/mL; 4 [hp_X]/mL; 5 [hp_X]/mL; 6 [hp_X]/mL; 6 [this 58048-0005-01 Bhp 60 ml — — FDA listed —
About this product: other versions of the same ingredient, strength and form are listed above, least expensive first, with FDA equivalence ratings where available.
Where does this data come from?
Equivalents are other NDCs of the same ingredient, form and route from the openFDA NDC Directory, ranked least-expensive-first by NADAC. Therapeutic-equivalence (AB) ratings come from the FDA Orange Book; biologics use the FDA Purple Book for biosimilar & interchangeable status.

Availability & generic status

🏛️
2020
On the market since
Mar 2020
📍
2026
Currently FDA-listed
6 years listed
🔒
·
No generic listed yet
brand only
ℹ️No FDA-approved generic found

We did not find an FDA-approved generic match for this exact strength, form and route.

Where does this data come from?
Patents and exclusivity from the FDA Orange Book (small-molecule drugs), refreshed from public FDA data. Generic launch timing is an estimate, not a guarantee.

Inactive Ingredients / Excipients

Inactive ingredients, also called excipients, are components of the drug product other than the active ingredient. They may include fillers, dyes, coatings, preservatives, flavors, or other formulation ingredients.

💡 Tap an ingredient (hover on desktop) to see what it is and why it’s used.

  • UNII 3K9958V90M
    A liquid solvent derived from fermentation or chemical synthesis. In medicines, alcohol dissolves active ingredients, helps preserve the product, and improves how the body absorbs certain drugs.
  • UNII 059QF0KO0R
    Water is a liquid solvent that dissolves and mixes ingredients together in liquid medicines, syrups, and injections. It helps distribute the active drug evenly throughout the product.

2 inactive ingredients listed in the exact product block matched to this NDC.

The official label also statesDemineralized Water and Organic Alcohol (Ethanol) 20%.

Label-section wording can be broader than the structured product block and may mention additional formulation ingredients.

Where does this data come from?
Data sourced from official FDA Structured Product Labeling (SPL) via DailyMed — ingredient classCode="IACT" elements from the exact product block matched by this NDC. Label-section narrative from DailyMed / the openFDA label index is shown separately when available.

Inactive ingredient FAQ

Are inactive ingredients the same for every manufacturer?
No. Inactive ingredients can differ by manufacturer, dosage form, strength, and package / product version.
Why might an inactive ingredient be missing?
Some SPLs do not provide a complete structured inactive-ingredient list, and older or unusual labels may only include the information in narrative text.
Can inactive ingredients matter?
Yes. They can matter for allergies, intolerances, dyes, gluten / lactose concerns, preservatives, and formulation differences — but confirm with a pharmacist or the manufacturer when it’s clinically important.

Manufacturer & labeler

LabelerBhp Holdings, Inc.
Labeler code58048
First marketedMar 2020
Product typeHuman Otc Drug
Portfolio2 products on file

More NDCs from Bhp Holdings, Inc. labeler code 58048

The labeler markets the product; the application holder owns the FDA approval. They’re often the same company but can differ (e.g. a repackager or an authorized generic). A mailing address / phone appears here when the manufacturer includes it in the product’s FDA label (not all do).
Where does this data come from?
Labeler, application holder and registered establishment from the FDA openFDA NDC Directory and Drugs@FDA; address/contact from the product’s FDA label.

FDA label — Drug Facts FDA SPL

The complete FDA label for this product — the official Drug Facts labeling, verbatim, section by section. Jump with a chip, search within the label, or expand everything.
🎯 Indications and Usage ⏱️ Dosage and Administration ⚠️ Warnings 🧪 Active Ingredient 🧪 Inactive Ingredients 🎯 Purpose 📄 Keep Out of Reach of Children 📄 Questions or Comments 📄 Package Label / Principal Display Panel
🎯 Indications and Usage 13 words ▾

INDICATIONS: Supports the immune system for host resistance to Lyme disease and co-infections.

⏱️ Dosage and Administration 37 words ▾

DIRECTIONS: Take 10 drops 1 to 3 times per day under the tongue 30 minutes before meal or as directed by a Health Care Practitioner. Consult your physician for use in children under 12 years of age.

⚠️ Warnings 52 words ▾

WARNINGS: If pregnant or nursing ask your health Care Practitioner before use. Keep out of reach of children. In case of overdose, get medical help or contact a Poison Control Center right away. Do not use if tamper evident seal is broken or missing. Store in a cool, dry and dark place.

🧪 Active Ingredient 79 words ▾

ACTIVE INGREDIENTS: Angelica Archangelica 2X, Kali Muriaticum 3X, Yucca Filamentosa 3X, Cartilago Suis 4X, 6X, 12X, Phytolacca Decandra 4X, 12X, 30X, Hydrastis Canadensis 5X, Rhus Tox 6X, Causticum 6X, 12X, 30X, Magnesia Phosphorica 8X, Manganum Metallicum 8X, Oxalicum Acidum 8X, 12X, Arnica Montana 8X, 100X, 1000X, Babesia Microti 12X, 30X, 60X, Borrelia Burgdorferi Nosode 12X, 30X, 60X, Latrodectus Mactans 12X, 30X, 60X, Citricum Acidum 6C, Cytomegalovirus Nosode 6C, Rickettsia Nosode (Rickettsia prowazekii) 8C, Chlamydia Trachomatis 12C, Ledum Palustre 30C.

🧪 Inactive Ingredients 9 words ▾

INACTIVE INGREDIENTS: Demineralized Water and Organic Alcohol (Ethanol) 20%.

🎯 Purpose 13 words ▾

INDICATIONS: Supports the immune system for host resistance to Lyme disease and co-infections.

📄 Keep Out of Reach of Children 27 words ▾

KEEP OUT OF REACH OF CHILDREN: Keep out of reach of children. In case of overdose, get medical help or contact a Poison Control Center right away.

📄 Questions or Comments 27 words ▾

QUESTIONS: Manufactured for: BHP Holdings, Inc. Woodinville, WA 98072 Phone: 425-462-8414 www.biopureus.com [email protected] Formulated and produced under the guidelines of the Homeopathic Pharmacopoeia of the United States.

📄 Package Label / Principal Display Panel 17 words ▾

PACKAGE LABEL DISPLAY: 58048-0005-1 BioPure Lyme & Co-Infection NOSODE HOMEOPATHIC 2 fl.oz (60mL) Lyme & Co-Infection Nosode

Source: FDA Structured Product Labeling, mirrored from DailyMed / openFDA. Prefer the government’s original formatting? View this label on DailyMed ↗

About this NDC listing & data coverage

Over-the-counter (OTC) product Homeopathic listing

About homeopathic listings

Lyme and Co-Infection Nosode Angelica Archangelica, Kali Muriaticum, Yucca Filamentosa, Cartilago Suis, Phytolacca Decandra, Hydrastis Canadensis, Rhus Tox, Causticum, Magnesia Phosphorica, Manganum Metallicum, Oxalicum Acidum, Arnica Montana, Babesia Microti, Borrelia Burgdorferi No 2 [hp_X]/mL; 3 [hp_X]/mL; 3 [hp_X]/mL; 4 [hp_X]/mL; 4 [hp_X]/mL; 5 [hp_X]/mL; 6 [hp_X]/mL; 6 [ LIQUID is listed under the homeopathic marketing category. An NDC listing in this category does not by itself establish FDA approval, and FDA does not evaluate homeopathic products for effectiveness. This page reports the listing data as published.

What data is (and isn’t) available for this NDC — tap to expand
NDC identity (package / product / labeler codes) ✓ Available
Labeler ✓ Available
Product & package description ✓ Available
Marketing category & status ✓ Available
Active ingredient / dosage form / route ✓ Available
FDA label (SPL via DailyMed) ✓ Available
Package photos ✓ Available
Inactive ingredients (structured) ✓ Available
NADAC pharmacy acquisition price (CMS) — Not published for this NDC CMS publishes NADAC only for NDCs reported in its retail-pharmacy survey.
Orange Book / therapeutic-equivalence data — Not published for this NDC Applies only to products approved under an NDA/ANDA; many listings are out of scope.
HCPCS J-code billing crosswalk — Not published for this NDC Most self-administered / retail products have no J-code — that is normal.
Medicaid utilization (CMS SDUD) — Not published for this NDC CMS reports utilization only for NDCs with Medicaid claims above its privacy threshold.
“Not published” reflects what the public FDA / CMS / NLM sources provide for this exact package code — it is a property of the data feeds, not a judgment about the product.

Questions about this listing

Is this NDC FDA-approved?
An NDC listing does not by itself establish FDA approval — the NDC Directory records that a product is listed with FDA, not that it was reviewed and approved. This listing's marketing category is "Unapproved Homeopathic". Products approved under an application carry an NDA, ANDA, or BLA number.
Why is there no price listed?
The pricing shown on our NDC pages comes from CMS NADAC, a voluntary survey of retail community pharmacy invoices. CMS does not publish a NADAC for every NDC — packages outside the retail survey (institutional and hospital products, bulk packages, discontinued items, and many OTC items) may never receive one. A missing price reflects the survey's scope, not this product's actual cost, and does not mean the product is free or unavailable.
Is the NDC printed on the package the same as the 11-digit billing NDC?
Yes, they identify this exact package in different formats. The form printed on the packaging and shown on DailyMed is the one the FDA registered. Insurance claims use a fixed 11-digit 5-4-2 format, so the short segment is padded with a leading zero and the dashes are dropped. The Identity section at the top of this page lists each form of this code.
Is this package still being marketed?
Yes, per the latest FDA NDC Directory data on this page it is currently marketed — but Bhp Holdings, Inc. has reported a marketing end date of 2027-09-19, after which this package is expected to stop being marketed. The directory data on this page refreshes weekly.
Who lists this product with the FDA?
Bhp Holdings, Inc. is the labeler of record for this NDC — the company under whose FDA-assigned code the package is listed. The labeler may be the manufacturer itself or a distributor marketing the product under its own code.
Do I need a prescription for this product?
This NDC is listed with FDA as an over-the-counter product, so it does not require a prescription. Follow the package directions, and ask your pharmacist if you are unsure whether it is right for you.
This page identifies an FDA-listed package (the NDC) and reports public regulatory and pricing data about the listing. It is reference information, not a medical recommendation — talk to your pharmacist or prescriber about your own medication.
Where does this data come from?
Listing facts (marketing category, packager status, marketing dates) from the FDA openFDA NDC Directory; label availability from DailyMed; pricing coverage from CMS NADAC; equivalence scope from the FDA Orange Book.
← 58037-0211-01 · New 58048-0006-01 · Bhp →
For educational and professional reference only — not medical advice. Pricing reflects published NADAC and CMS ASP (free public data) and may differ from your acquisition cost; always verify before billing or dispensing.